Article Text

Download PDFPDF
Fifteen-minute consultation: How to manage eczema in children
  1. Sophie Constantinou1,
  2. Jordan Evans2,3,
  3. Richard Geoffrey Goodwin4
  1. 1 Department of Medicine, University Hospital of Wales, Cardiff, UK
  2. 2 Paediatric Emergency Department, University Hospital of Wales, Cardiff, UK
  3. 3 Emergency Department, The Children's Hospital at Westmead, The Sydney Children's Hospitals Network, Westmead, New South Wales, Australia
  4. 4 Paediatric Dermatology, Aneurin Bevan University Health Board, Newport, UK
  1. Correspondence to Dr Sophie Constantinou, Department of Medicine, University Hospital of Wales, Cardiff CF14 4XW, UK; sophie.constantinou{at}wales.nhs.uk

Abstract

Atopic eczema is common and has a major impact on quality of life. Paediatricians and general practitioners play a key role in the non-specialist treatment of atopic eczema. However, the clinical nature of the diagnosis, multitude of topical therapies and sometimes complicated treatment strategies can leave both clinicians and families feeling bewildered. This article aims to provide a concise, patient-focused summary of the assessment and management of childhood atopic eczema.

  • dermatology
  • microbiology
  • therapeutics

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Collaborators Sue Lewis; David Tuthill.

  • Contributors SC wrote the body of the manuscript and contributed to revisions. JE conceived the idea for the article, produced the figures and contributed to the manuscript and its revisions. RGG reviewed the manuscript, provided expert advice/supervision and contributed to revisions.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.